CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Key Highlights
- ➤1-for-10 reverse split effective before October 26, 2026 market open
- ➤Nasdaq listing compliance and $1.00 minimum bid price drive action
- ➤Outstanding shares expected to decrease from approximately 10,331,116 to 1,033,112
- ➤PRP Phase 1b first-in-human study planned for up to 50 patients in Q1 2027
Expert Statements
James Nathanielsz, Chief Executive Officer of Propanc Biopharma
“The Reverse Stock Split is being implemented to enable the Company to expeditiously restore compliance with the continued listing standards of the Nasdaq Stock Market and Nasdaq’s $1.00 minimum bid price requirement and support future growth plans.”
James Nathanielsz, Chief Executive Officer of Propanc Biopharma
“We are excited about the advancement of our lead asset, PRP, as we prepare for our Phase 1b, First-In-Human (FIH) study, in up to 50 advanced cancer patients with solid tumors in the first quarter of 2027.”
James Nathanielsz, Chief Executive Officer of Propanc Biopharma
“By undertaking this important corporate action, we will clear the pathway for execution of future R&D milestone events that we believe will be transformative for the Company and its shareholders.”
MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, please note that in the third paragraph of the release, the "Reverse Stock Split date" should be "October 26, 2026," not "October 19, 2026," as previously stated. This correction is being issued to reflect the correct Reverse Stock Split date. The corrected release follows:
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, today announced that its Board of Directors, approved a 1-for-10 reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (“Reverse Stock Split”). The Reverse Stock Split is anticipated to be effective as of the open of the market October 26, 2026.
Get started
Create a free account to read the full story.